Overall, the results obtained in the current study demonstrated that LINC00858 affects the progression of colon cancer and revealed that LINC00858 is able to recruit RAD21 to upregulate PCNP, which contributes to STAT3/5 signaling activation, thereby promoting the development of colon cancer (Fig. 7). Here, LINC00858 is linked to colonic neoplasm.